Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.0B | 5.3B | 4.9B | 5.1B |
Cost of revenue | 3.2B | 3.5B | 3.3B | 3.4B |
Gross profit | 1.7B | 1.8B | 1.6B | 1.7B |
Operating expense | ||||
Research & development | 190.5M | 218.9M | 183.9M | 195.2M |
Selling general and admin | 534.6M | 535.5M | 534.0M | 565.9M |
Other operating expenses | — | — | — | — |
Operating income | 1.0B | 1.0B | 922.2M | 969.9M |
Non operating interest income | ||||
Income | 1.2M | 17.9M | 3.6M | 14.9M |
Expense | 70.6M | 88.2M | 94.8M | 100.1M |
Other income expense | — | — | — | — |
Pretax income | 1.1B | 997.5M | 817.3M | 1.1B |
Tax provision | 230.6M | 184.2M | 173.8M | 263.6M |
Net income | 833.8M | 813.3M | 643.6M | 813.4M |
Basic EPS | 5.0 | — | 3.9 | 4.9 |
Diluted EPS | 5.0 | — | 3.8 | 4.9 |
Basic average shares | 165.8M | — | 165.9M | 165.8M |
Diluted average shares | 167.6M | — | 166.7M | 166.5M |
EBITDA | 1.7B | 1.7B | 1.5B | 1.8B |
Net income from continuing op. | 1.1B | 997.5M | 817.3M | 1.1B |
Minority interests | 2.7M | -3.1M | -4.9M | -797K |
Preferred stock dividends | 0 | 0 | 0 | 0 |